A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier treatment.

New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

A prospective study found that a multicancer blood test detected signals across 17 cancer types with 99.64% specificity, but ...

Learn about a new blood test that could lead to earlier detection and treatment of breast cancer.

Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. Here's what to know.

Proteins present in men’s blood could give clues to prostate cancer risk years before diagnosis. View on euronews ...

Researchers at USC have launched an early-stage clinical trial to investigate whether a blood test could help detect breast ...

Editor's note: This article was updated after the U.S. Food and Drug Administration approved the Galleri cancer test kit. When the Galleri test hit the market in 2021, it sounded enticing — it ...

Blood-based colorectal cancer screening is scaling fast, and a second FDA-approved test launched Sept. 30. For GI ASCs, the question is whether those tests feed colonoscopy volume or replace it. The ...

When you breathe out, you're not just releasing carbon dioxide. Your breath carries a complex mix of volatile organic compounds, or VOCs—tiny molecules that come from normal body processes. These ...

Key TakeawaysFreenome shares rose 11% today after it launched SimpleScreen Lung, a lung cancer blood test that can run with its FDA-approved colon cancer test from one blood draw. About half of people ...